Surface expression of CTLA-4 is detectable by reverse transcriptase- PCR in all cell lines derived from a variety of human malignant solid tumors including carcinoma, melanoma, neuroblastoma, rhabdomyosarcoma and osteosarcoma (Contardi et al., 2005). This evidence concerns the gene CTLA4 and melanoma.